SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease
Autoimmune disease treatment developer SetPoint Medical announced today that it raised $80 million in a preferred stock financing.
Source: massdevice.com
Murthyv Simhambhatla News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Murthyv Simhambhatla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Murthyv Simhambhatla Today - Breaking & Trending Today
SetPoint Medical Raises $80M in Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform January 27, 2021 09:00 ET | Source: SetPoint Medical SetPoint Medical Valencia, California VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflammation-mediated autoimmune diseases and is i...
Source: globenewswire.com